| Preface | |
| List of Contributors | |
| Quantitative coronary arteriography (QCA) versus other modalities | |
| A pathologist's view of quantitative coronary arteriography | p. 3 |
| Angioscopy versus angiography for the detection of coronary artery disease surface morphology | p. 15 |
| Development and application of coronary intravascular ultrasound: comparison to quantitative angiography | p. 29 |
| QCA: cinefilm versus digital arteriography | |
| Quantitative analysis of the cineangiogram: Why bother? | p. 55 |
| Quantitative coronary arteriography: equipment and technical requirements | p. 75 |
| The filmless catheterization laboratory: when will it be reality? | p. 113 |
| Quality control in QCA | |
| Optimal frame selection for QCA | p. 125 |
| Variability of QCA-core laboratory assessment of coronary anatomy | p. 137 |
| Automated physical assessment of image quality in digital cardiac imaging | p. 161 |
| Experiences of a quantitative coronary angiographic core laboratory in restenosis prevention trials | p. 177 |
| Coronary blood flow and flow reserve | |
| Flow and flow reserve by parametric imaging | p. 195 |
| Maximal myocardial perfusion as a measure of the functional significance of coronary artery disease | p. 213 |
| Angiographic measurement of coronary blood flow | p. 235 |
| QCA in regression/progression of atherosclerotic disease | |
| Value and limitations of quantitative coronary angiography to assess progression or regression of coronary atherosclerosis | p. 255 |
| The impact of the calcium antagonist nifedipine on the angiographic progression of coronary artery disease - results of INTACT (International Nifedipine Trial on Anti-atherosclerotic Therapy) | p. 273 |
| Progression and regression of coronary atherosclerosis: data from a controlled clinical trial with Nicardipine | p. 285 |
| Computer quantitative measurements of CLAS coronary angiograms compared to evaluation by panels of human angiographers | p. 299 |
| A maximum confidence strategy for measuring progression and regression of coronary artery disease in clinical trials | p. 311 |
| QCA in restenosis studies | |
| Pharmacological prevention of restenosis after percutaneous transluminal coronary angioplasty (PTCA); overview and methodological considerations | p. 329 |
| CARPORT - Coronary Artery Restenosis Prevention On Repeated Thromboxane Antagonism. A multicenter randomized clinical trial | p. 351 |
| Angiotensin converting enzyme inhibition in the prevention of restenosis: the MERCATOR and MARCATOR trials | p. 365 |
| Historic. A multicenter randomized clinical trial to evaluate feasibility and tolerability of recombinant congener of hirudin as an alternative to heparin during PTCA | p. 373 |
| Angiopeptin in experimental models of restenosis | p. 377 |
| Cyclic flow alterations and neointimal proliferation following experimental coronary stenosis and endothelial injury | p. 385 |
| QCA after recanalization techniques in coronary arteries | |
| The use of quantitative coronary angiography (QCA) in interventional cardiology | p. 397 |
| Quantitative coronary arteriography in laser balloon angioplasty | p. 443 |
| Quantitative coronary angiography after directional coronary atherectomy | p. 459 |
| Directional coronary atherectomy evaluation by quantitative angiography | p. 473 |
| Quantitative results and lesion morphology in coronary excimer laser angioplasty | p. 485 |
| Percutaneous transluminal coronary rotational ablation: early follow-up at 24 hours by quantitative angiography | p. 497 |
| Quantitative assessment of the residual stenosis after percutaneous transluminal coronary rotary ablation: European experience | p. 515 |
| Quantitative coronary angiography after revascularization with the Transluminal Extraction - Endarterectomy Catheter (TEC) | p. 525 |
| QCA and intracoronary prostheses | |
| An experimental cardiologist's view on coronary stents | p. 537 |
| The Palmaz-Schatz stent | p. 553 |
| The Wallstent experience: 1986-1990 | p. 567 |
| Immediate and long-term clinical and angiographic results following Wiktor stent implantation in patients with documented restenosis of a native coronary artery lesion following prior balloon angioplasty | p. 593 |
| Coronary Gianturco-Roubin Stents | p. 609 |
| Index | p. 625 |
| Table of Contents provided by Blackwell. All Rights Reserved. |
